English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Characteristics of clinical trials of new oncology drugs approved in China Journal article
Yang, Jing, Yang, Ji, Hu, Yuan Jia. Characteristics of clinical trials of new oncology drugs approved in China[J]. Cancer, 2024, 130(5), 671-682.
Authors:  Yang, Jing;  Yang, Ji;  Hu, Yuan Jia
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:6.1/6.7 | Submit date：2024/05/16
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Characteristics of clinical trials of new oncology drugs approved in China Review article
2023
Authors:  Jing Yang;  Ji Yang;  HU YUANJIA
Adobe PDF | Favorite | TC[WOS]:2 TC[Scopus]:2  IF:6.1/6.7 | Submit date：2024/01/02
Clinical Evidence  Drug Lag  Novel Anticancer Drugs  Pivotal Clinical Trials  Programmed Death-1 (Pd-1) Inhibitors  Programmed Death-ligand 1 (Pd-l1) Inhibitors  
Targeting PD-L1 Protein: Translation, Modification and Transport Journal article
Wei R., Guo L., Wang Q., Miao J., Kwok H.F., Lin Y.. Targeting PD-L1 Protein: Translation, Modification and Transport[J]. Current protein & peptide science, 2019, 20(1), 82-91.
Authors:  Wei R.;  Guo L.;  Wang Q.;  Miao J.;  Kwok H.F.; et al.
Favorite | TC[WOS]:22 TC[Scopus]:22  IF:1.9/3.0 | Submit date：2018/12/19
Immunotherapy  Modification  Programmed Cell Death Protein 1 (Pd-1)  Programmed Death Ligand 1 (Pd-l1)  Translation  Transport.  
Global patent landscape of programmed cell death 1: implications of the rapid expansion Journal article
Kong, Xiangjun, Zhang, Qianru, Lai, Yunfeng, Hu, Hao, Chen, Xin, Hu, Yuanjia. Global patent landscape of programmed cell death 1: implications of the rapid expansion[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28(1), 69-80.
Authors:  Kong, Xiangjun;  Zhang, Qianru;  Lai, Yunfeng;  Hu, Hao;  Chen, Xin; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:5.4/6.4 | Submit date：2018/10/30
Programmed Cell Death 1 (Pd-1)  Patent Landscape  Patent Citation Network  Co-patent  Technology Flow  Immunotherapy  
The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint Journal article
Wang, Qingshui, Lin, Wei, Tang, Xiaoqiong, Li, Suhuan, Guo, Libin, Lin, Yao, Kwok, Hang Fai. The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18(12).
Authors:  Wang, Qingshui;  Lin, Wei;  Tang, Xiaoqiong;  Li, Suhuan;  Guo, Libin; et al.
Favorite | TC[WOS]:95 TC[Scopus]:95 | Submit date：2018/10/30
Programmed Death-ligand 1 (Pd-l1)  Programmed Death 1(Pd-1)  Micrornas  Immune Checkpoint  
The roles of microRNAs in regulating the expression of PD-1/PD-l1 immune checkpoint Journal article
Wang,Qingshui, Lin,Wei, Tang,Xiaoqiong, Li,Suhuan, Guo,Libin, Lin,Yao, Kwok,Hang Fai. The roles of microRNAs in regulating the expression of PD-1/PD-l1 immune checkpoint[J]. International Journal of Molecular Sciences, 2017, 18(12).
Authors:  Wang,Qingshui;  Lin,Wei;  Tang,Xiaoqiong;  Li,Suhuan;  Guo,Libin; et al.
Favorite | TC[WOS]:95 TC[Scopus]:95  IF:4.9/5.6 | Submit date：2021/03/04
Immune Checkpoint  Micrornas  Programmed Death 1(Pd-1)  Programmed Death-ligand 1 (Pd-l1)